It has been a common practice for lawyers to act as local counsel in lawsuits. Local counsel are typically relied on by out-of-state attorneys when it comes to complying with local rules, reviewing pleadings, and moving for the pro hac vice admission of lead counsel. While acting as local counsel can be beneficial to clients and counsel alike, if not properly guided, various ethical issues may arise.
In this LIVE Webcast, a panel of thought leaders and professionals brought together by The Knowledge Group will provide and present an in-depth analysis of the fundamentals as well as recent developments in Structuring Effective Real Estate Finance Transactions: Key Considerations and Strategies.
Halfway into President Trump's administration, the Department of Justice (DOJ) provided a clearer image of its enforcement priorities for the False Claims Act (FCA).
The Standard Essential Patent (SEP) litigation landscape continues to evolve as years pass. Interestingly, its interplay with other legal areas presents unique challenges for businesses and patent owners.
Several regulatory updates and trends on consumer law have resulted in thousands of consumer class actions over the last few years. Concurrently, the present economic upheaval brought by the COVID-19 pandemic fueled a spike in the number of consumer lawsuits filed from various industries.
The COVID-19 pandemic has brought an immense economic toll on businesses across the globe. Specifically, it prompted a spike in the number of lost profit damages lawsuits as businesses seek to recover lost profits because of pandemic-related damages. However, although there are various damage calculation theories available, pandemic-related lost profit claims can be taxing and challenging. Thus, businesses and their counsel must always exercise diligence in documenting their revenues and profits. They must also be abreast of emerging regulatory developments to avoid pitfalls.
The spread of the coronavirus has massively disrupted the way lawyers fulfill their obligations to their clients. From work-from-home set-up to virtual proceedings, lawyers had to adjust to the new means of working.
The swift and unregulated development of artificial intelligence (AI) is significantly affecting innovation and the intellectual property (IP) landscape. As AI-based products, applications, and techniques continue to emerge in high volume, IP protection and enforcement issues are expected to increase.
Today's business landscape has been significantly confronted with profound economic disruptions and income losses due to the impact of the COVID-19 pandemic. These disruptions have made business interruption insurance a standard component for several business sectors seeking assistance in recovering lost revenue amid the crisis.
The COVID-19 pandemic is reshaping antitrust law enforcement across the globe. Recognizing the need for a closer cooperation among private businesses, the US government seems to be more flexible now in reviewing COVID-19-related competitor collaborations. In April, both the Department of Justice (DOJ) and the Federal Trade Commission (FTC) announced the expedited seven-day evaluation procedure, which typically takes months for traditional business reviews.
The current COVID-19 crisis has greatly impacted all industries across the world and the legal industry is no exception. Recently conducted studies show how the pandemic instigated a spike in the stress and anxiety levels of lawyers. Thus, a significant increase of alcoholism, mental health distress, and other related health problems had been noted in the legal industry.
Ethics plays a crucial role in the legal industry. Because they are expected to uphold their integrity and professional responsibility at all times, lawyers must not only be critical about their actions but also mindful and proactive in understanding the ins and outs of legal ethics.
Yearly regulatory updates from the United States Patent and Trademark Office (USPTO) constantly shape the post-grant patent trials landscape. This year’s proposed guidelines entail amendments on the rules surrounding standard practices in post-grant review (PGR), inter partes review (IPR), and covered business method (CBM).
Commercial litigation is among the many areas of law affected by the impact of the COVID-19 pandemic, which resulted in several case delays and significant business litigation proceeding restrictions. Furthermore, the currently implemented remote hearings also add a great deal of uncertainty and this will likely continue for a period of time as in-person arrangements are not possible yet. These issues bring further complexities and challenges in the determination of proceedings and trials, thus creating a crucial need to be conversant with the nuances of the situation and other updates.
As the biosimilar industry continues to grow, significant legal developments and trends also continue to emerge and pose challenges to market participants. Questions currently hounding the future of the Biologics Price Competition and Innovation Act (BPCIA) litigation and regulatory pathway include the newly introduced Biologic Patent Transparency Act, the ongoing debates on the constitutionality of the Affordable Care Act (ACA), and the potential unavailability of inter partes and post-grant review proceedings for biosimilar manufacturers.
